
Ontacef S 375mg Injection
Marketer
Fitwel Pharmaceuticals Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ontacef S 375mg Injection
Cefotaxime 375mg Injection (Ontacef S equivalent) is a blended medication used to combat diverse bacterial infections. Its action inhibits microbial proliferation, thus curbing infection spread. Administration must be under a healthcare provider's direct guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course of treatment is essential, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek emergency care for allergic reactions such as rashes, itching, swelling, or respiratory distress. Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. Pregnant or lactating individuals require specific medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is usually unaffected, refrain from driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and ample hydration support recovery. Monitoring treatment effectiveness may involve diagnostic tests ordered by your doctor.
Primary Ingredients of Ontacef S 375mg Injection
No text provided. Please provide the text you want me to rephrase.
Uses of Ontacef S 375mg Injection
Infections caused by bacteria
Major Benefits of Ontacef S 375mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ontacef S 375mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ontacef S 375mg Injection:
Administering this medication will be handled by your physician or their qualified staff; self-medication is strictly prohibited.
How Ontacef S 375mg Injection works:
The injectable formulation Ontacef S 375mg combines ceftriaxone, a broad-spectrum antibiotic, with sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam counteracts bacterial resistance mechanisms, thereby optimizing ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ontacef S 375mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Ontacef S (375mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human pregnancies remain scarce.
Breast feedingCAUTION
The administration of Ontacef S 375mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ontacef S 375mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ontacef S 375mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Cefotaxime 375mg injection requires careful administration in patients exhibiting severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for this injection is not advised for individuals with mild to moderate liver dysfunction.
What if you forget to take Ontacef S 375mg Injection :
Should you inadvertently omit a scheduled dose of Ontacef S 375mg Injection, seek immediate medical advice.
Facts to Know About Ontacef S 375mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
